Article

newatlas.com on 2022-02-14 01:22

New Omicron-targeting antibody therapy for COVID authorized by FDA

The FDA has issued an emergency use authorization for bebtelovimab, a monoclonal antibody designed to reduce risk of hospitalization and death from ...

Carl Hansen

Related news

MNew monoclonal antibody drug for COVID authorized, FDA says. It works against omicron miamiherald.com
FDA grants emergency authorization to new Eli Lilly antibody therapy for use against omicron staradvertiser.com
New York , Indianapolis
FDA Authorizes Eli Lilly’s Covid Antibody Therapy For Emergency Use In Young Children Forbes
FDA authorizes new antibody drug to fight omicron pressherald.com
FDA grants emergency approval to experimental COVID-19 antibody therapy newatlas.com
Phase 2
FDA Authorizes Eli Lilly Antibody Treatment That Fights Omicron Forbes
Vír , Spain , Madrid , Alcobendas
Virus antibody therapy for kids gets FDA nod Arkansas Online
Immunocore gets FDA approval for cell therapy targeting melanoma bizjournals.com
FDA committee endorses omicron-targeting Covid booster strategy bizjournals.com
IEli Lilly, Regeneron COVID treatments de-authorized by FDA as ineffective vs. omicron indystar.com
Indiana
FDA halts use of antibody drugs that don’t work vs. omicron Merced Sun-Star
Texas , Florida , Pittsboro
FDA pulls authorization of 3rd COVID antibody drug due to ‘stealth omicron’bangordailynews.com
Vír , Philadelphia
FDA authorizes new monoclonal antibody drug said to work against omicron San Jose Mercury News